Overview
Infected conjunctival abrasions occur when the conjunctiva, the clear membrane covering the white part of the eye and the inner surface of the eyelids, sustains a scratch or tear, often leading to bacterial contamination and subsequent infection. This condition is clinically significant due to its potential to cause significant ocular discomfort, impaired vision, and if untreated, serious complications such as corneal ulceration and vision loss. It commonly affects individuals who engage in activities that increase the risk of ocular trauma, such as contact sports, manual labor, or those with certain ocular conditions like dry eye syndrome. Prompt recognition and management are crucial in day-to-day practice to prevent complications and ensure optimal patient outcomes 14.Pathophysiology
The pathophysiology of infected conjunctival abrasions typically begins with physical trauma to the conjunctiva, which disrupts its protective barrier function. This disruption exposes underlying tissues to environmental pathogens, particularly bacteria such as Staphylococcus aureus and Pseudomonas aeruginosa. Once these microorganisms breach the conjunctival surface, they can proliferate in the presence of devitalized tissue and exudates, leading to localized inflammation and infection. The inflammatory response involves the recruitment of neutrophils and macrophages, which release pro-inflammatory cytokines and enzymes that further damage ocular tissues if unchecked. Over time, this process can extend to deeper ocular structures, including the cornea, potentially resulting in ulceration and more severe visual impairment 14.Epidemiology
The incidence of conjunctival abrasions is not extensively documented in large epidemiological studies, but they are relatively common occurrences, particularly among individuals with occupational hazards or recreational activities involving ocular trauma. Age and sex distributions are not markedly skewed, though younger individuals and those with preexisting ocular conditions may be at higher risk. Geographic factors can influence exposure risks, with occupational settings in certain regions posing greater hazards. Trends over time suggest an increasing awareness of protective measures, but the absolute incidence remains stable due to persistent risk factors 4.Clinical Presentation
Infected conjunctival abrasions typically present with symptoms such as redness, pain, purulent discharge, and photophobia. Patients may report a history of recent trauma, often from foreign bodies, fingernails, or other sharp objects. Red-flag features include severe pain disproportionate to the apparent injury, significant decrease in visual acuity, and the presence of hypopyon (pus in the anterior chamber of the eye). These signs necessitate urgent evaluation to rule out deeper ocular involvement such as corneal ulceration. Prompt recognition of these atypical presentations is critical for timely intervention 14.Diagnosis
The diagnostic approach for infected conjunctival abrasions involves a thorough history and physical examination, focusing on the nature and timing of trauma, associated symptoms, and visual acuity. Specific criteria and tests include:Differential Diagnosis:
Management
Initial Management
Secondary and Refractory Management
Contraindications:
Complications
Prognosis & Follow-up
The prognosis for infected conjunctival abrasions is generally good with prompt and appropriate treatment. Key prognostic indicators include the depth of the abrasion, the causative organism, and the timeliness of intervention. Recommended follow-up intervals typically include:Special Populations
Key Recommendations
References
1 Jeencham R, Sutheerawattananonda M, Rungchang S, Tiyaboonchai W. Novel daily disposable therapeutic contact lenses based on chitosan and regenerated silk fibroin for the ophthalmic delivery of diclofenac sodium. Drug delivery 2020. link 2 Chong SJ, Smith C, Bialostocki A, McEwan CN. Do modern spectacles endanger surgeons? The Waikato Eye Protection Study. Annals of surgery 2007. link 3 Si EC, Bowman LM, Hosseini K. Pharmacokinetic comparisons of bromfenac in DuraSite and Xibrom. Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics 2011. link 4 Ogendo SW, Awori MN, Omondi MA, Mulatya EM, Mugo PW. Risk of conjunctival contamination from blood splashes during surgery at the Kenyatta National Hospital, Nairobi. East African medical journal 2008. link